rs9332975
From SNPedia
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (A;A) | 0 | common in clinvar |
| Make rs9332975(A;G) |
| Make rs9332975(G;G) |
| Reference | GRCh38 38.1/142 |
| Chromosome | 2 |
| Position | 31525347 |
| Gene | SRD5A2 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs9332975 |
| dbSNP (classic) | rs9332975 |
| ClinGen | rs9332975 |
| ebi | rs9332975 |
| HLI | rs9332975 |
| Exac | rs9332975 |
| Gnomad | rs9332975 |
| Varsome | rs9332975 |
| LitVar | rs9332975 |
| Map | rs9332975 |
| PheGenI | rs9332975 |
| Biobank | rs9332975 |
| 1000 genomes | rs9332975 |
| hgdp | rs9332975 |
| ensembl | rs9332975 |
| geneview | rs9332975 |
| scholar | rs9332975 |
| rs9332975 | |
| pharmgkb | rs9332975 |
| gwascentral | rs9332975 |
| openSNP | rs9332975 |
| 23andMe | rs9332975 |
| SNPshot | rs9332975 |
| SNPdbe | rs9332975 |
| MSV3d | rs9332975 |
| GWAS Ctlg | rs9332975 |
| GMAF | 0.1276 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
[PMID 23499746] SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists
| ClinVar | |
|---|---|
| Risk | rs9332975(G;G) |
| Alt | rs9332975(G;G) |
| Reference | Rs9332975(A;A) |
| Significance | Probable-non-pathogenic |
| Disease | not provided 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| Variation | info |
| Gene | SRD5A2 |
| CLNDBN | not provided 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| Reversed | 1 |
| HGVS | NC_000002.11:g.31750417T>C |
| CLNSRC | ClinVar |
| CLNACC | RCV000083668.1, RCV000365985.1, |
